International

Curated By Isabella Tang

By Isabella Tang 2026-07-21

Akeso Initiates Phase II Study of Novel Bispecific ADC for Advanced NSCLC

Akeso has announced the first patient has been dosed in a Phase II clinical trial of its innovative TROP2/Nectin-4 bispecific antibody-drug conjugate, AK146D1, in combination with Ivonescimab for treating advanced non-small cell lung cancer (NSCLC). This promising development highlights the potential of targeted therapies in oncology and the ongoing commitment to improving patient outcomes in cancer treatment.

By Isabella Tang 2026-07-21

Antengene Showcases Promising Cancer Treatments at ESMO 2026

Antengene Corporation has announced the presentation of its innovative cancer therapies ATG-022 and ATG-037 at the European Society for Medical Oncology (ESMO) 2026 Congress. The company aims to highlight the potential of these treatments in improving patient outcomes in oncology.

By Isabella Tang 2026-07-20

Global Supply Chain Disruptions: Navigating the New Normal

As the world grapples with ongoing supply chain disruptions, businesses are adapting to a landscape reshaped by the pandemic and geopolitical tensions. This report explores the challenges and strategies companies are employing to maintain resilience in their operations.